1
|
Phutthacharoen K, Llanos-López NA, Toshe R, Noisripoom W, Khonsanit A, Luangsa-ard JJ, Hyde KD, Ebada SS, Stadler M. Bioactive Bioxanthracene and Cyclodepsipeptides from the Entomopathogenic Fungus Blackwellomyces roseostromatus BCC56290. Antibiotics (Basel) 2024; 13:585. [PMID: 39061267 PMCID: PMC11273930 DOI: 10.3390/antibiotics13070585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2024] [Revised: 06/15/2024] [Accepted: 06/22/2024] [Indexed: 07/28/2024] Open
Abstract
In the course of our ongoing research targeting the identification of potential biocontrol agents from entomopathogenic fungi (EPF), we explored a solid-state rice fungal extract of Blackwellomyces roseostromatus BCC56290 derived from infected lepidopteran larvae. Chemical and biological prospections afforded four unprecedentedly reported natural products differentiated into a dimeric naphthopyran bioxanthracene ES-242 derivative (1) and three cyclodepsipeptides (2-4) in addition to two known cyclodepsipeptides, cardinalisamides B (5) and C (6). Chemical structures of the isolated compounds were elucidated through comprehensive 1D/2D NMR and HR-ESI-MS data together with comparisons to the reported literature. The absolute configuration of the isolated cyclodepsipeptides was determined using Marfey's method. All isolated compounds were assessed for their antimicrobial, cytotoxic, and nematicidal activities with some compounds revealing significant activities.
Collapse
Affiliation(s)
- Kunthida Phutthacharoen
- Department of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany; (K.P.); (N.A.L.-L.); (R.T.)
- Center of Excellence in Fungal Research, Mae Fah Luang University, Chiang Rai 57100, Thailand;
| | - Natalia A. Llanos-López
- Department of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany; (K.P.); (N.A.L.-L.); (R.T.)
- Institute of Microbiology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany
| | - Rita Toshe
- Department of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany; (K.P.); (N.A.L.-L.); (R.T.)
- Institute of Microbiology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany
| | - Wasana Noisripoom
- National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand; (W.N.); (A.K.); (J.J.L.-a.)
| | - Artit Khonsanit
- National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand; (W.N.); (A.K.); (J.J.L.-a.)
| | - Janet Jennifer Luangsa-ard
- National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), 113 Thailand Science Park, Phahonyothin Rd., Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand; (W.N.); (A.K.); (J.J.L.-a.)
| | - Kevin D. Hyde
- Center of Excellence in Fungal Research, Mae Fah Luang University, Chiang Rai 57100, Thailand;
- School of Science, Mae Fah Luang University, Chiang Rai 57100, Thailand
| | - Sherif S. Ebada
- Department of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany; (K.P.); (N.A.L.-L.); (R.T.)
- Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt
| | - Marc Stadler
- Department of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany; (K.P.); (N.A.L.-L.); (R.T.)
- Institute of Microbiology, Technische Universität Braunschweig, Spielmannstraße 7, 38106 Braunschweig, Germany
| |
Collapse
|
2
|
Wennrich JP, Ebada SS, Sepanian E, Holzenkamp C, Khalid SJ, Schrey H, Maier W, Mándi A, Kurtán T, Ashrafi S, Stadler M. Omnipolyphilins A and B: Chlorinated Cyclotetrapeptides and Naphtho-α-pyranones from the Plant Nematode-Derived Fungus Polyphilus sieberi. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2024; 72:6998-7009. [PMID: 38507729 PMCID: PMC10995996 DOI: 10.1021/acs.jafc.4c00572] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/19/2024] [Revised: 02/29/2024] [Accepted: 03/05/2024] [Indexed: 03/22/2024]
Abstract
Chemical exploration for two isolates of the recently described ascomycete species Polyphilus sieberi, derived from the eggs of the plant parasitic nematode Heterodera filipjevi, afforded the identification of many compounds that belong to various metabolite families: two previously undescribed chlorinated cyclotetrapeptides, omnipolyphilins A (1) and B (2), one new pyranonaphthoquinone, ventiloquinone P (3), a 6,6'-binaphto-α-pyranone dimer, talaroderxine D (4) in addition to nine known metabolites (5-13) were isolated from this biocontrol candidate. All isolated compounds were characterized by comprehensive 1D, 2D NMR, and HR-ESI-MS analyses. The absolute configurations of the cyclotetrapeptides were determined by a combination of advanced Marfey's method, ROE correlation aided by conformational analysis, and TDDFT-ECD calculations, while ECD calculations, Mosher's method, and experimental ECD spectra were used for ventiloquinone P (3) and talaroderxine D (4). Among the isolated compounds, talaroderxine D (4) showed potent antimicrobial activities against Bacillus subtilis and Staphylococcus aureus with MIC values of 2.1 and 8.3 μg mL-1, respectively. Additionally, promising inhibitory effects on talaroderxine D (4) against the formation of S. aureus biofilms were observed up to a concentration of 0.25 μg mL-1. Moreover, ophiocordylongiiside A (10) showed activity against the free-living nematode Caenorhabditis elegans.
Collapse
Affiliation(s)
- Jan-Peer Wennrich
- Department
of Microbial Drugs, Helmholtz Centre for
Infection Research GmbH (HZI) and German Centre for Infection Research
(DZIF), Inhoffenstraße 7, 38124 Braunschweig, Germany
- Institute
of Microbiology, Technische Universität
Braunschweig, Spielmannstraße
7, 38106 Braunschweig, Germany
| | - Sherif S. Ebada
- Department
of Microbial Drugs, Helmholtz Centre for
Infection Research GmbH (HZI) and German Centre for Infection Research
(DZIF), Inhoffenstraße 7, 38124 Braunschweig, Germany
- Department
of Pharmacognosy, Faculty of Pharmacy, Ain
Shams University, 11566 Cairo, Egypt
| | - Ellen Sepanian
- Department
of Microbial Drugs, Helmholtz Centre for
Infection Research GmbH (HZI) and German Centre for Infection Research
(DZIF), Inhoffenstraße 7, 38124 Braunschweig, Germany
| | - Caren Holzenkamp
- Department
of Microbial Drugs, Helmholtz Centre for
Infection Research GmbH (HZI) and German Centre for Infection Research
(DZIF), Inhoffenstraße 7, 38124 Braunschweig, Germany
- Institute
of Microbiology, Technische Universität
Braunschweig, Spielmannstraße
7, 38106 Braunschweig, Germany
| | - Syeda J. Khalid
- Department
of Microbial Drugs, Helmholtz Centre for
Infection Research GmbH (HZI) and German Centre for Infection Research
(DZIF), Inhoffenstraße 7, 38124 Braunschweig, Germany
- Institute
of Microbiology, Technische Universität
Braunschweig, Spielmannstraße
7, 38106 Braunschweig, Germany
| | - Hedda Schrey
- Department
of Microbial Drugs, Helmholtz Centre for
Infection Research GmbH (HZI) and German Centre for Infection Research
(DZIF), Inhoffenstraße 7, 38124 Braunschweig, Germany
- Institute
of Microbiology, Technische Universität
Braunschweig, Spielmannstraße
7, 38106 Braunschweig, Germany
| | - Wolfgang Maier
- Institute
for Epidemiology and Pathogen Diagonstics, Julius Kühn Institut (JKI) - Federal Research Center for Cultivated
Plants, Messeweg 11-12, 38104 Braunschweig, Germany
| | - Attila Mándi
- Department
of Organic Chemistry, University of Debrecen, P.O. Box 400, 4002 Debrecen, Hungary
| | - Tibor Kurtán
- Department
of Organic Chemistry, University of Debrecen, P.O. Box 400, 4002 Debrecen, Hungary
| | - Samad Ashrafi
- Institute
for Epidemiology and Pathogen Diagonstics, Julius Kühn Institut (JKI) - Federal Research Center for Cultivated
Plants, Messeweg 11-12, 38104 Braunschweig, Germany
- Institute
for Crop and Soil Science, Julius Kühn
Institute (JKI) − Federal Research Centre for Cultivated Plants, Bundesallee 58, 38116 Braunschweig, Germany
| | - Marc Stadler
- Department
of Microbial Drugs, Helmholtz Centre for
Infection Research GmbH (HZI) and German Centre for Infection Research
(DZIF), Inhoffenstraße 7, 38124 Braunschweig, Germany
- Institute
of Microbiology, Technische Universität
Braunschweig, Spielmannstraße
7, 38106 Braunschweig, Germany
| |
Collapse
|
3
|
Thetsana C, Kobayashi R, Manadee K, Kodani S. Isolation and structure determination of a new depsipeptide crocapeptin C from the myxobacterium Melittangium boletus. Nat Prod Res 2024:1-7. [PMID: 38270086 DOI: 10.1080/14786419.2024.2308719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2023] [Accepted: 01/16/2024] [Indexed: 01/26/2024]
Abstract
A new cyclic depsipeptide, crocapeptin C (1), containing 3-amino-6-hydroxy-2-piperidone (Ahp) was isolated from the methanol extract of the myxobacterium Melittangium boletus. The chemical structure of crocapeptin C (1) was determined through NMR and ESI-MS analysis. The stereochemistries of the constituent amino acids in crocapeptin C (1) were determined using the advanced Marfey's method and ROESY spectrum data. Crocapeptin C (1) exhibited potent inhibitory activity against chymotrypsin with an IC50 value of 0.5 µM.
Collapse
Affiliation(s)
- Chanaphat Thetsana
- Graduate School of Science and Technology, Shizuoka University, Shizuoka, Japan
| | - Ryo Kobayashi
- Graduate School of Integrated Science and Technology, Shizuoka University, Shizuoka, Japan
| | - Kanitta Manadee
- Graduate School of Integrated Science and Technology, Shizuoka University, Shizuoka, Japan
- Department of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand
| | - Shinya Kodani
- Graduate School of Science and Technology, Shizuoka University, Shizuoka, Japan
- Graduate School of Integrated Science and Technology, Shizuoka University, Shizuoka, Japan
- College of Agriculture, Academic Institute, Shizuoka University, Shizuoka, Japan
| |
Collapse
|
4
|
Konkel R, Cegłowska M, Szubert K, Wieczerzak E, Iliakopoulou S, Kaloudis T, Mazur-Marzec H. Structural Diversity and Biological Activity of Cyanopeptolins Produced by Nostoc edaphicum CCNP1411. Mar Drugs 2023; 21:508. [PMID: 37888443 PMCID: PMC10608790 DOI: 10.3390/md21100508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2023] [Revised: 09/22/2023] [Accepted: 09/24/2023] [Indexed: 10/28/2023] Open
Abstract
Cyanopeptolins (CPs) are one of the most commonly occurring class of cyanobacterial nonribosomal peptides. For the majority of these compounds, protease inhibition has been reported. In the current work, the structural diversity of cyanopeptolins produced by Nostoc edaphicum CCNP1411 was explored. As a result, 93 CPs, including 79 new variants, were detected and structurally characterized based on their mass fragmentation spectra. CPs isolated in higher amounts were additionally characterized by NMR. To the best of our knowledge, this is the highest number of cyanopeptides found in one strain. The biological assays performed with the 34 isolated CPs confirmed the significance of the amino acid located between Thr and the unique 3-amino-6-hydroxy-2-piperidone (Ahp) on the activity of the compounds against serine protease and HeLa cancer cells.
Collapse
Affiliation(s)
- Robert Konkel
- Department of Marine Biology and Biotechnology, Faculty of Oceanography and Geography, University of Gdańsk, PL-81378 Gdynia, Poland; (R.K.); (K.S.)
| | - Marta Cegłowska
- Institute of Oceanology, Polish Academy of Sciences, Powstańców Warszawy 55, PL-81712 Sopot, Poland;
| | - Karolina Szubert
- Department of Marine Biology and Biotechnology, Faculty of Oceanography and Geography, University of Gdańsk, PL-81378 Gdynia, Poland; (R.K.); (K.S.)
| | - Ewa Wieczerzak
- Department of Biomedical Chemistry, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, PL-80308 Gdańsk, Poland;
| | - Sofia Iliakopoulou
- Department of Sustainable Agriculture, University of Patras, GR-30131 Agrinio, Greece;
| | - Triantafyllos Kaloudis
- Institute of Nanoscience & Nanotechnology, NCSR Demokritos, GR-15310 Agia Paraskevi, Greece;
- Laboratory of Organic Micropollutants, Water Quality Control Department, EYDAP SA, Menidi, GR-13674 Athens, Greece
| | - Hanna Mazur-Marzec
- Department of Marine Biology and Biotechnology, Faculty of Oceanography and Geography, University of Gdańsk, PL-81378 Gdynia, Poland; (R.K.); (K.S.)
| |
Collapse
|
5
|
Park J, Kim J, Hwang S, Oh D, Du YE, Nam SJ, Park HG, Lee MJ, Oh DC. Sadopeptins A and B, Sulfoxide- and Piperidone-Containing Cyclic Heptapeptides with Proteasome Inhibitory Activity from a Streptomyces sp. JOURNAL OF NATURAL PRODUCTS 2023; 86:612-620. [PMID: 36921317 DOI: 10.1021/acs.jnatprod.2c00978] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/18/2023]
Abstract
New sulfur-bearing natural products, sadopeptins A and B (1 and 2), were discovered from Streptomyces sp. YNK18 based on a targeted search using the characteristic isotopic signature of sulfur in mass spectrometry analysis. Compounds 1 and 2 were determined to be new cyclic heptapeptides, bearing methionine sulfoxide [Met(O)] and 3-amino-6-hydroxy-2-piperidone (Ahp), based on 1D and 2D NMR spectroscopy along with IR, UV, and MS. The configurations of sadopeptins A and B (1 and 2) were established via the analysis of the ROESY NMR correlation, oxidation, Marfey's method, and circular dichroism (CD) spectroscopy. The bioinformatics analysis of the full Streptomyces sp. YNK18 genome identified a nonribosomal peptide synthetase (NRPS) biosynthetic gene cluster (BGC), and a putative biosynthetic pathway is proposed. Sadopeptins A and B displayed proteasome-inhibitory activity without affecting cellular autophagic flux.
Collapse
Affiliation(s)
- Jiyoon Park
- Natural Products Research Institute, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea
| | - Jiseong Kim
- Department of Biomedical Sciences, College of Medicine, Seoul National University, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea
| | - Sunghoon Hwang
- Natural Products Research Institute, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea
| | - Daehyun Oh
- Research Institute of Pharmaceutical Sciences and College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea
| | - Young Eun Du
- Natural Products Research Institute, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea
| | - Sang-Jip Nam
- Department of Chemistry and Nanoscience, Ewha Womans University, Seoul 03760, Republic of Korea
| | - Hyeung-Geun Park
- Research Institute of Pharmaceutical Sciences and College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea
| | - Min Jae Lee
- Department of Biomedical Sciences, College of Medicine, Seoul National University, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea
| | - Dong-Chan Oh
- Natural Products Research Institute, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea
| |
Collapse
|
6
|
Morinagadepsin, a Depsipeptide from the Fungus Morinagamyces vermicularis gen. et comb. nov. Microorganisms 2021; 9:microorganisms9061191. [PMID: 34073017 PMCID: PMC8230337 DOI: 10.3390/microorganisms9061191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2021] [Revised: 05/25/2021] [Accepted: 05/27/2021] [Indexed: 11/30/2022] Open
Abstract
The new genus Morinagamyces is introduced herein to accommodate the fungus Apiosordaria vermicularis as inferred from a phylogenetic study based on sequences of the internal transcribed spacer region (ITS), the nuclear rDNA large subunit (LSU), and partial fragments of ribosomal polymerase II subunit 2 (rpb2) and β-tubulin (tub2) genes. Morinagamyces vermicularis was analyzed for the production of secondary metabolites, resulting in the isolation of a new depsipeptide named morinagadepsin (1), and the already known chaetone B (3). While the planar structure of 1 was elucidated by extensive 1D- and 2D-NMR analysis and high-resolution mass spectrometry, the absolute configuration of the building blocks Ala, Val, and Leu was determined as -l by Marfey’s method. The configuration of the 3-hydroxy-2-methyldecanyl unit was assigned as 22R,23R by J-based configuration analysis and Mosher’s method after partial hydrolysis of the morinagadepsin to the linear derivative compound 2. Compound 1 showed cytotoxic activity against the mammalian cell lines KB3.1 and L929, but no antimicrobial activity against the fungi and bacteria tested was observed, while 2 was inactive. Compound 3 was weakly cytotoxic against the cell line L929, but did not show any antimicrobial activity.
Collapse
|
7
|
Köcher S, Resch S, Kessenbrock T, Schrapp L, Ehrmann M, Kaiser M. From dolastatin 13 to cyanopeptolins, micropeptins, and lyngbyastatins: the chemical biology of Ahp-cyclodepsipeptides. Nat Prod Rep 2021; 37:163-174. [PMID: 31451830 DOI: 10.1039/c9np00033j] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Covering: 1989 up to 2019 Ahp-cyclodepsipeptides (also known as Ahp-containing cyclodepsipeptides, cyanopeptolins, micropeptins, microginines, and lyngbyastatins, and by many other names) are a family of non-ribosomal peptide synthesis (NRPS)-derived natural products with potent serine protease inhibitory properties. Here, we review their isolation and structural elucidation from natural sources as well as studies of their biosynthesis, molecular mode of action, and use in drug discovery efforts. Accordingly, this summary aims to provide a comprehensive overview of the current state-of-the-art Ahp-cyclodepsipeptide research.
Collapse
Affiliation(s)
- Steffen Köcher
- Chemical Biology, Zentrum für Medizinische Biotechnologie (ZMB), Faculty of Biology, Universität Duisburg-Essen, Universitätsstr. 2, 45117 Essen, Germany.
| | - Sarah Resch
- Chemical Biology, Zentrum für Medizinische Biotechnologie (ZMB), Faculty of Biology, Universität Duisburg-Essen, Universitätsstr. 2, 45117 Essen, Germany.
| | - Till Kessenbrock
- Chemical Biology, Zentrum für Medizinische Biotechnologie (ZMB), Faculty of Biology, Universität Duisburg-Essen, Universitätsstr. 2, 45117 Essen, Germany.
| | - Lukas Schrapp
- Chemical Biology, Zentrum für Medizinische Biotechnologie (ZMB), Faculty of Biology, Universität Duisburg-Essen, Universitätsstr. 2, 45117 Essen, Germany.
| | - Michael Ehrmann
- Microbiology, Zentrum für Medizinische Biotechnologie (ZMB), Faculty of Biology, Universität Duisburg-Essen, Universitätsstr. 2, 45117 Essen, Germany
| | - Markus Kaiser
- Chemical Biology, Zentrum für Medizinische Biotechnologie (ZMB), Faculty of Biology, Universität Duisburg-Essen, Universitätsstr. 2, 45117 Essen, Germany.
| |
Collapse
|
8
|
Khodamoradi S, Stadler M, Wink J, Surup F. Litoralimycins A and B, New Cytotoxic Thiopeptides from Streptomonospora sp. M2. Mar Drugs 2020; 18:md18060280. [PMID: 32466459 PMCID: PMC7345755 DOI: 10.3390/md18060280] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Revised: 05/18/2020] [Accepted: 05/20/2020] [Indexed: 11/23/2022] Open
Abstract
Streptomonospora sp. M2 has been isolated from a soil sample collected at the Wadden Sea beach in our ongoing program aimed at the isolation of rare Actinobacteria, ultimately targeting the discovery of new antibiotics. Because crude extracts derived from cultures of this strain showed inhibitory activity against the indicator organism Bacillus subtilis, it was selected for further analysis. HPLC–MS analysis of its culture broth revealed the presence of lipophilic metabolites. The two major metabolites of those were isolated by preparative reversed-phase HPLC and preparative TLC. Their planar structures were elucidated using high-resolution electrospray ionization mass spectrometry (HRESIMS), 1D and 2D NMR data as new thiopeptide antibiotics and named litoralimycin A (1) and B (2). Although rotating frame nuclear Overhauser effect spectroscopy (ROESY) data established a Z configuration of the Δ21,26 double bond, the stereochemistry of C-5 and C-15 were assigned as S by Marfey’s method after ozonolysis. The biological activity spectrum of 1 and 2 is highly uncommon for thiopeptide antibiotics, since they showed only insignificant antibacterial activity, but 1 showed strong cytotoxic effects.
Collapse
Affiliation(s)
- Shadi Khodamoradi
- Microbial Strain Collection, Helmholtz-Centre for Infection Research (HZI), Inhoffenstr. 7, 38124 Braunschweig, Germany;
- German Centre for Infection Research (DZIF), partner site Hannover-Braunschweig, 38124 Braunschweig, Germany;
| | - Marc Stadler
- German Centre for Infection Research (DZIF), partner site Hannover-Braunschweig, 38124 Braunschweig, Germany;
- Microbial Drugs Department, Helmholtz-Centre for Infection Research (HZI), Inhoffenstr. 7, 38124 Braunschweig, Germany
| | - Joachim Wink
- Microbial Strain Collection, Helmholtz-Centre for Infection Research (HZI), Inhoffenstr. 7, 38124 Braunschweig, Germany;
- German Centre for Infection Research (DZIF), partner site Hannover-Braunschweig, 38124 Braunschweig, Germany;
- Correspondence: (J.W.); (F.S.); Tel.: +49-351-6181-4223 (J.W.); +49-351-6181-4256 (F.S.)
| | - Frank Surup
- German Centre for Infection Research (DZIF), partner site Hannover-Braunschweig, 38124 Braunschweig, Germany;
- Microbial Drugs Department, Helmholtz-Centre for Infection Research (HZI), Inhoffenstr. 7, 38124 Braunschweig, Germany
- Correspondence: (J.W.); (F.S.); Tel.: +49-351-6181-4223 (J.W.); +49-351-6181-4256 (F.S.)
| |
Collapse
|
9
|
Bader CD, Panter F, Müller R. In depth natural product discovery - Myxobacterial strains that provided multiple secondary metabolites. Biotechnol Adv 2019; 39:107480. [PMID: 31707075 DOI: 10.1016/j.biotechadv.2019.107480] [Citation(s) in RCA: 40] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2019] [Revised: 11/05/2019] [Accepted: 11/06/2019] [Indexed: 12/28/2022]
Abstract
In recognition of many microorganisms ability to produce a variety of secondary metabolites in parallel, Zeeck and coworkers introduced the term "OSMAC" (one strain many compounds) around the turn of the century. Since then, additional efforts focused on the systematic characterization of a single bacterial species ability to form multiple secondary metabolite scaffolds. With the beginning of the genomic era mainly initiated by a dramatic reduction of sequencing costs, investigations of the genome encoded biosynthetic potential and especially the exploitation of biosynthetic gene clusters of undefined function gained attention. This was seen as a novel means to extend range and diversity of bacterial secondary metabolites. Genome analyses showed that even for well-studied bacterial strains, like the myxobacterium Myxococcus xanthus DK1622, many biosynthetic gene clusters are not yet assigned to their corresponding hypothetical secondary metabolites. In contrast to the results from emerging genome and metabolome mining techniques that show the large untapped biosynthetic potential per strain, many newly isolated bacterial species are still used for the isolation of only one target compound class and successively abandoned in the sense that no follow up studies are published from the same species. This work provides an overview about myxobacterial bacterial strains, from which not just one but multiple different secondary metabolite classes were successfully isolated. The underlying methods used for strain prioritization and natural product discovery such as biological characterization of crude extracts against a panel of pathogens, in-silico prediction of secondary metabolite abundance from genome data and state of the art instrumental analytics required for new natural product scaffold discovery in comparative settings are summarized and classified according to their output. Furthermore, for each approach selected studies performed with actinobacteria are shown to underline especially innovative methods used for natural product discovery.
Collapse
Affiliation(s)
- Chantal D Bader
- Department Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy, Saarland University, Campus E8.1, 66123 Saarbrücken, Germany; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Germany
| | - Fabian Panter
- Department Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy, Saarland University, Campus E8.1, 66123 Saarbrücken, Germany; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Germany
| | - Rolf Müller
- Department Microbial Natural Products, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy, Saarland University, Campus E8.1, 66123 Saarbrücken, Germany; German Center for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Germany.
| |
Collapse
|
10
|
Tiwari A, Kaweewan I, Miyake Y, Hemmi H, Kodani S. Isolation and structure determination of new chymotrypsin inhibitory peptides streptopeptolins B and C. Nat Prod Res 2019; 35:2700-2706. [DOI: 10.1080/14786419.2019.1663514] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
- Ankit Tiwari
- Graduate School of Integrated Science and Technology, Shizuoka University, Shizuoka, Japan
| | - Issara Kaweewan
- Graduate School of Science and Technology, Shizuoka University, Shizuoka, Japan
| | - Yuto Miyake
- Graduate School of Integrated Science and Technology, Shizuoka University, Shizuoka, Japan
| | - Hikaru Hemmi
- Food Research Institute, National Agriculture and Food Research Organization (NARO), Tsukuba, Ibaraki, Japan
| | - Shinya Kodani
- Graduate School of Integrated Science and Technology, Shizuoka University, Shizuoka, Japan
- Graduate School of Science and Technology, Shizuoka University, Shizuoka, Japan
- Academic Institute, Shizuoka University, Shizuoka, Japan
| |
Collapse
|
11
|
Kaysser L. Built to bind: biosynthetic strategies for the formation of small-molecule protease inhibitors. Nat Prod Rep 2019; 36:1654-1686. [DOI: 10.1039/c8np00095f] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
The discovery and characterization of natural product protease inhibitors has inspired the development of numerous pharmaceutical agents.
Collapse
Affiliation(s)
- Leonard Kaysser
- Department of Pharmaceutical Biology
- University of Tübingen
- 72076 Tübingen
- Germany
- German Centre for Infection Research (DZIF)
| |
Collapse
|
12
|
Auerbach D, Yan F, Zhang Y, Müller R. Characterization of an Unusual Glycerate Esterification Process in Vioprolide Biosynthesis. ACS Chem Biol 2018; 13:3123-3130. [PMID: 30286293 DOI: 10.1021/acschembio.8b00826] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Bacteria produce a large number of secondary metabolites with extraordinary chemical structures and bioactivities. Vioprolides are promising anticancer and antifungal lead compounds produced by the myxobacterium Cystobacter violaceus Cb vi35, which are initially synthesized as acylated precursors (previoprolides) by nonribosomal peptide synthetases (NRPS). Here, we describe and characterize an unprecedented glycerate esterification process in the biosynthesis of vioprolides. In vitro biochemical investigations revealed that the fatty acyl chain of previoprolides is adenylated by the starting fatty acyl-AMP ligase (FAAL) domain, while the glycerate moiety is incorporated by the FkbH domain. An unusual ester-bond forming condensation domain is shown responsible for the acylation of glycerate. LC-MS analysis and bioactivity assays suggest that the acylation serves for directed membrane transport rather than representing a prodrug mechanism.
Collapse
Affiliation(s)
- David Auerbach
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research and Department of Pharmacy, Saarland University, Saarland University Campus, Building E8.1, 66123 Saarbrücken, Germany
| | - Fu Yan
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research and Department of Pharmacy, Saarland University, Saarland University Campus, Building E8.1, 66123 Saarbrücken, Germany
| | - Youming Zhang
- Shandong University-Helmholtz Joint Institute of Biotechnology, State Key Laboratory of Microbial Technology, School of Life Science, Shandong University, Qingdao, People’s Republic of China
| | - Rolf Müller
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research and Department of Pharmacy, Saarland University, Saarland University Campus, Building E8.1, 66123 Saarbrücken, Germany
| |
Collapse
|
13
|
Yang L, Li H, Wu P, Mahal A, Xue J, Xu L, Wei X. Dinghupeptins A-D, Chymotrypsin Inhibitory Cyclodepsipeptides Produced by a Soil-Derived Streptomyces. JOURNAL OF NATURAL PRODUCTS 2018; 81:1928-1936. [PMID: 30222343 DOI: 10.1021/acs.jnatprod.7b01009] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Four new cyclodepsipeptides, dinghupeptins A-D (1-4), possessing a rare N5-(2-hydroxylethyl)glutamine moiety, were isolated from cultures of the soil-derived Streptomyces sp. SC0581. Their structures were elucidated by spectroscopic and advanced Marfey's amino acid analysis, and their 3D structures were established by theoretical conformational analysis. Compounds 1 and 2, containing a 3-amino-6-hydroxypiperidone unit, displayed selective inhibition of chymotrypsin with IC50 values of 2.1 and 1.1 μM, respectively. Enzyme kinetic analysis and molecular docking experiments revealed they are competitive inhibitors binding to the active site of chymotrypsin.
Collapse
Affiliation(s)
- Li Yang
- Key Laboratory of Plant Resources Conservation and Sustainable Utilization/Guangdong Provincial Key Laboratory of Applied Botany , South China Botanical Garden, Chinese Academy of Sciences , Xingke Road 723 , Tianhe District, Guangzhou 510650 , People's Republic of China
- School of Life Sciences , University of Chinese Academy of Sciences , Yuquanlu 19A , Beijing 100049 , People's Republic of China
| | - Hanxiang Li
- Key Laboratory of Plant Resources Conservation and Sustainable Utilization/Guangdong Provincial Key Laboratory of Applied Botany , South China Botanical Garden, Chinese Academy of Sciences , Xingke Road 723 , Tianhe District, Guangzhou 510650 , People's Republic of China
| | - Ping Wu
- Key Laboratory of Plant Resources Conservation and Sustainable Utilization/Guangdong Provincial Key Laboratory of Applied Botany , South China Botanical Garden, Chinese Academy of Sciences , Xingke Road 723 , Tianhe District, Guangzhou 510650 , People's Republic of China
| | - Ahmed Mahal
- Key Laboratory of Plant Resources Conservation and Sustainable Utilization/Guangdong Provincial Key Laboratory of Applied Botany , South China Botanical Garden, Chinese Academy of Sciences , Xingke Road 723 , Tianhe District, Guangzhou 510650 , People's Republic of China
| | - Jinghua Xue
- Key Laboratory of Plant Resources Conservation and Sustainable Utilization/Guangdong Provincial Key Laboratory of Applied Botany , South China Botanical Garden, Chinese Academy of Sciences , Xingke Road 723 , Tianhe District, Guangzhou 510650 , People's Republic of China
| | - Liangxiong Xu
- Key Laboratory of Plant Resources Conservation and Sustainable Utilization/Guangdong Provincial Key Laboratory of Applied Botany , South China Botanical Garden, Chinese Academy of Sciences , Xingke Road 723 , Tianhe District, Guangzhou 510650 , People's Republic of China
| | - Xiaoyi Wei
- Key Laboratory of Plant Resources Conservation and Sustainable Utilization/Guangdong Provincial Key Laboratory of Applied Botany , South China Botanical Garden, Chinese Academy of Sciences , Xingke Road 723 , Tianhe District, Guangzhou 510650 , People's Republic of China
| |
Collapse
|
14
|
Kodani S, Komaki H, Hemmi H, Miyake Y, Kaweewan I, Dohra H. Streptopeptolin, a Cyanopeptolin-Type Peptide from Streptomyces olivochromogenes. ACS OMEGA 2018; 3:8104-8110. [PMID: 30087936 PMCID: PMC6072256 DOI: 10.1021/acsomega.8b01042] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 05/18/2018] [Accepted: 07/06/2018] [Indexed: 06/08/2023]
Abstract
Cyanopeptolin-type peptides are cyclic depsipeptides that commonly have 3-amino-6-hydroxy-2-piperidone (Ahp) unit in the molecules. So far, cyanopeptolin-type peptides have been isolated as protease inhibitors from a wide variety of cyanobacteria. In the course of screening for new peptides, a new peptide streptopeptolin, which had the similar structure to cyanopeptolin, was isolated from the extract of Streptomyces olivochromogenes NBRC 3561. Streptopeptolin is the first cyanopeptolin-type peptide isolated from actinobacteria. The structure of streptopeptolin was determined by the analysis of electrospray ionization mass spectrometry and NMR to be cyclic depsipeptide containing unusual amino acids, Ahp, and N-methyl tyrosine. As a result of protease inhibition test, streptopeptolin showed inhibitory activity against chymotrypsin. The whole genome sequence data of S. olivochromogenes revealed the biosynthetic gene cluster for streptopeptolin, which encoded a nonribosomal peptide synthetase. We proposed a biosynthetic pathway of streptopeptolin based on bioinformatics analysis.
Collapse
Affiliation(s)
- Shinya Kodani
- Academic
Institute, Graduate School of Integrated Science and Technology, Graduate School of
Science and Technology, Research Institute of Green Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka, Shizuoka 422-8529, Japan
| | - Hisayuki Komaki
- Biological
Resource Center, National Institute of Technology
and Evaluation (NBRC), 2-5-8 Kazusakamatari, Kisarazu, Chiba 292-0818, Japan
| | - Hikaru Hemmi
- Food
Research
Institute, National Agriculture and Food
Research Organization (NARO), 2-1-12 Kannondai, Tsukuba, Ibaraki 305-8642, Japan
| | - Yuto Miyake
- Academic
Institute, Graduate School of Integrated Science and Technology, Graduate School of
Science and Technology, Research Institute of Green Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka, Shizuoka 422-8529, Japan
| | - Issara Kaweewan
- Academic
Institute, Graduate School of Integrated Science and Technology, Graduate School of
Science and Technology, Research Institute of Green Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka, Shizuoka 422-8529, Japan
| | - Hideo Dohra
- Academic
Institute, Graduate School of Integrated Science and Technology, Graduate School of
Science and Technology, Research Institute of Green Science and Technology, Shizuoka University, 836 Ohya, Suruga-ku, Shizuoka, Shizuoka 422-8529, Japan
| |
Collapse
|
15
|
Surup F, Viehrig K, Rachid S, Plaza A, Maurer CK, Hartmann RW, Müller R. Crocadepsins-Depsipeptides from the Myxobacterium Chondromyces crocatus Found by a Genome Mining Approach. ACS Chem Biol 2018; 13:267-272. [PMID: 29220569 DOI: 10.1021/acschembio.7b00900] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
Analysis of the genome sequence of the myxobacterium Chondromyces crocatus Cm c5 revealed the presence of numerous cryptic megasynthetase gene clusters, one of which we here assign to two previously unknown chlorinated metabolites by a comparative gene inactivation and secondary metabolomics approach. Structure elucidation of these compounds revealed a unique cyclic depsipeptide skeleton featuring β- and δ-amide bonds of aspartic acid and 3-methyl ornithine moieties, respectively. Insights into their biosynthesis were obtained by targeted gene inactivation and feeding experiments employing isotope-labeled precursors. The compounds were produced ubiquitously by the species Chondromyces crocatus and were found to inhibit the carbon storage regulator-RNA interaction.
Collapse
Affiliation(s)
- Frank Surup
- Helmholtz Center
for Infection Research (HZI), Department Microbial Drugs, Inhoffenstraβe
7, 38124 Braunschweig, Germany
- German Centre for Infection Research Association (DZIF), partner site Hannover-Braunschweig, Inhoffenstraβe 7, 38124 Braunschweig, Germany
| | - Konrad Viehrig
- Helmholtz Institute for Pharmaceutical
Research Saarland (HIPS), Helmholtz Center for Infection Research
and Pharmaceutical Biotechnology, Saarland University, Campus, Building C2.3, 66123 Saarbrücken, Germany
| | - Shwan Rachid
- Helmholtz Institute for Pharmaceutical
Research Saarland (HIPS), Helmholtz Center for Infection Research
and Pharmaceutical Biotechnology, Saarland University, Campus, Building C2.3, 66123 Saarbrücken, Germany
| | - Alberto Plaza
- Helmholtz Institute for Pharmaceutical
Research Saarland (HIPS), Helmholtz Center for Infection Research
and Pharmaceutical Biotechnology, Saarland University, Campus, Building C2.3, 66123 Saarbrücken, Germany
| | - Christine K. Maurer
- Department of Drug Design & Optimization, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, Campus E8.1, 66123 Saarbrücken, Germany
- German Centre for Infection Research Association (DZIF), partner site Hannover-Braunschweig, Inhoffenstraβe 7, 38124 Braunschweig, Germany
| | - Rolf W. Hartmann
- Department of Drug Design & Optimization, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, Campus E8.1, 66123 Saarbrücken, Germany
- German Centre for Infection Research Association (DZIF), partner site Hannover-Braunschweig, Inhoffenstraβe 7, 38124 Braunschweig, Germany
| | - Rolf Müller
- Helmholtz Center
for Infection Research (HZI), Department Microbial Drugs, Inhoffenstraβe
7, 38124 Braunschweig, Germany
- Helmholtz Institute for Pharmaceutical
Research Saarland (HIPS), Helmholtz Center for Infection Research
and Pharmaceutical Biotechnology, Saarland University, Campus, Building C2.3, 66123 Saarbrücken, Germany
- German Centre for Infection Research Association (DZIF), partner site Hannover-Braunschweig, Inhoffenstraβe 7, 38124 Braunschweig, Germany
| |
Collapse
|
16
|
Köcher S, Rey J, Bongard J, Tiaden AN, Meltzer M, Richards PJ, Ehrmann M, Kaiser M. Maßgeschneiderte Ahp-Cyclodepsipeptide als potente, nicht-kovalente Serinprotease-Inhibitoren. Angew Chem Int Ed Engl 2017. [DOI: 10.1002/ange.201701771] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- Steffen Köcher
- Chemische Biologie, ZMB, Fakultät für Biologie; Universität Duisburg-Essen; Universitätsstraße 2 45117 Essen Deutschland
| | - Juliana Rey
- Mikrobiologie, ZMB, Fakultät für Biologie; Universität Duisburg-Essen; Deutschland
| | - Jens Bongard
- Mikrobiologie, ZMB, Fakultät für Biologie; Universität Duisburg-Essen; Deutschland
| | - André N. Tiaden
- Bone and Stem Cell Research Group, CABMM; Universität Zürich; Schweiz
| | - Michael Meltzer
- Mikrobiologie, ZMB, Fakultät für Biologie; Universität Duisburg-Essen; Deutschland
| | - Peter J. Richards
- Bone and Stem Cell Research Group, CABMM; Universität Zürich; Schweiz
- Zurich Center for Integrative Human Physiology (ZIHP); Universität Zürich; Schweiz
| | - Michael Ehrmann
- Mikrobiologie, ZMB, Fakultät für Biologie; Universität Duisburg-Essen; Deutschland
- School of Biosciences; Cardiff University; Großbritannien
| | - Markus Kaiser
- Chemische Biologie, ZMB, Fakultät für Biologie; Universität Duisburg-Essen; Universitätsstraße 2 45117 Essen Deutschland
| |
Collapse
|
17
|
Köcher S, Rey J, Bongard J, Tiaden AN, Meltzer M, Richards PJ, Ehrmann M, Kaiser M. Tailored Ahp-cyclodepsipeptides as Potent Non-covalent Serine Protease Inhibitors. Angew Chem Int Ed Engl 2017; 56:8555-8558. [PMID: 28514117 DOI: 10.1002/anie.201701771] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2017] [Indexed: 11/08/2022]
Abstract
The S1 serine protease family is one of the largest and most biologically important protease families. Despite their biomedical significance, generic approaches to generate potent, class-specific, bioactive non-covalent inhibitors for these enzymes are still limited. In this work, we demonstrate that Ahp-cyclodepsipeptides represent a suitable scaffold for generating target-tailored inhibitors of serine proteases. For efficient synthetic access, we developed a practical mixed solid- and solution-phase synthesis that we validated through performing the first chemical synthesis of the two natural products Tasipeptin A and B. The suitability of the Ahp-cyclodepsipeptide scaffold for tailored inhibitor synthesis is showcased by the generation of the most potent human HTRA protease inhibitors to date. We anticipate that our approach may also be applied to other serine proteases, thus opening new avenues for a systematic discovery of serine protease inhibitors.
Collapse
Affiliation(s)
- Steffen Köcher
- Chemical Biology, ZMB, University of Duisburg-Essen, Universitätsstr. 2, 45117, Essen, Germany
| | - Juliana Rey
- Microbiology, ZMB, University of Duisburg-Essen, Universitätsstr. 2, 45117, Essen, Germany
| | - Jens Bongard
- Microbiology, ZMB, University of Duisburg-Essen, Universitätsstr. 2, 45117, Essen, Germany
| | - André N Tiaden
- Bone and Stem Cell Research Group, CABMM, University of Zurich, Winterthurerstr. 190, 8057, Zürich, Switzerland
| | - Michael Meltzer
- Microbiology, ZMB, University of Duisburg-Essen, Universitätsstr. 2, 45117, Essen, Germany
| | - Peter J Richards
- Bone and Stem Cell Research Group, CABMM, University of Zurich, Winterthurerstr. 190, 8057, Zürich, Switzerland.,Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Winterthurerstr. 190, 8057, Zürich, Switzerland
| | - Michael Ehrmann
- Microbiology, ZMB, University of Duisburg-Essen, Universitätsstr. 2, 45117, Essen, Germany.,School of Biosciences, Cardiff University, Cardiff, CF10 3US, UK
| | - Markus Kaiser
- Chemical Biology, ZMB, University of Duisburg-Essen, Universitätsstr. 2, 45117, Essen, Germany
| |
Collapse
|
18
|
Chemische Struktur und Biosynthese der Crocagine, polycyclischer Peptide ribosomalen Ursprungs ausChondromyces crocatus. Angew Chem Int Ed Engl 2017. [DOI: 10.1002/ange.201612640] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
19
|
Viehrig K, Surup F, Volz C, Herrmann J, Abou Fayad A, Adam S, Köhnke J, Trauner D, Müller R. Structure and Biosynthesis of Crocagins: Polycyclic Posttranslationally Modified Ribosomal Peptides fromChondromyces crocatus. Angew Chem Int Ed Engl 2017; 56:7407-7410. [DOI: 10.1002/anie.201612640] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2016] [Revised: 03/08/2017] [Indexed: 11/11/2022]
Affiliation(s)
- Konrad Viehrig
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS); Helmholtz Center for Infection Research and Pharmaceutical Biotechnology; Saarland University; Campus, Building E8.1 66123 Saarbrücken Germany
| | - Frank Surup
- Helmholtz Center for Infection Research (HZI); Department Microbial Drugs; Inhoffenstraße 7 38124 Braunschweig Germany
- German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig; Germany
| | - Carsten Volz
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS); Helmholtz Center for Infection Research and Pharmaceutical Biotechnology; Saarland University; Campus, Building E8.1 66123 Saarbrücken Germany
| | - Jennifer Herrmann
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS); Helmholtz Center for Infection Research and Pharmaceutical Biotechnology; Saarland University; Campus, Building E8.1 66123 Saarbrücken Germany
| | - Antoine Abou Fayad
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS); Helmholtz Center for Infection Research and Pharmaceutical Biotechnology; Saarland University; Campus, Building E8.1 66123 Saarbrücken Germany
| | - Sebastian Adam
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS); Helmholtz Center for Infection Research and Pharmaceutical Biotechnology; Saarland University; Campus, Building E8.1 66123 Saarbrücken Germany
| | - Jesko Köhnke
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS); Helmholtz Center for Infection Research and Pharmaceutical Biotechnology; Saarland University; Campus, Building E8.1 66123 Saarbrücken Germany
| | - Dirk Trauner
- Department of Chemistry; Ludwig-Maximilians-Universität München; Butenandtstrasse 5-13 81377 Munich Germany
| | - Rolf Müller
- Helmholtz Institute for Pharmaceutical Research Saarland (HIPS); Helmholtz Center for Infection Research and Pharmaceutical Biotechnology; Saarland University; Campus, Building E8.1 66123 Saarbrücken Germany
- Helmholtz Center for Infection Research (HZI); Department Microbial Drugs; Inhoffenstraße 7 38124 Braunschweig Germany
- German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig; Germany
| |
Collapse
|
20
|
Süssmuth RD, Mainz A. Nonribosomal Peptide Synthesis-Principles and Prospects. Angew Chem Int Ed Engl 2017; 56:3770-3821. [PMID: 28323366 DOI: 10.1002/anie.201609079] [Citation(s) in RCA: 540] [Impact Index Per Article: 77.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2016] [Indexed: 01/05/2023]
Abstract
Nonribosomal peptide synthetases (NRPSs) are large multienzyme machineries that assemble numerous peptides with large structural and functional diversity. These peptides include more than 20 marketed drugs, such as antibacterials (penicillin, vancomycin), antitumor compounds (bleomycin), and immunosuppressants (cyclosporine). Over the past few decades biochemical and structural biology studies have gained mechanistic insights into the highly complex assembly line of nonribosomal peptides. This Review provides state-of-the-art knowledge on the underlying mechanisms of NRPSs and the variety of their products along with detailed analysis of the challenges for future reprogrammed biosynthesis. Such a reprogramming of NRPSs would immediately spur chances to generate analogues of existing drugs or new compound libraries of otherwise nearly inaccessible compound structures.
Collapse
Affiliation(s)
- Roderich D Süssmuth
- Technische Universität Berlin, Institut für Chemie, Strasse des 17. Juni 124, 10623, Berlin, Germany
| | - Andi Mainz
- Technische Universität Berlin, Institut für Chemie, Strasse des 17. Juni 124, 10623, Berlin, Germany
| |
Collapse
|
21
|
Süssmuth RD, Mainz A. Nicht-ribosomale Peptidsynthese - Prinzipien und Perspektiven. Angew Chem Int Ed Engl 2017. [DOI: 10.1002/ange.201609079] [Citation(s) in RCA: 80] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Affiliation(s)
- Roderich D. Süssmuth
- Technische Universität Berlin; Institut für Chemie; Straße des 17. Juni 124 10623 Berlin Deutschland
| | - Andi Mainz
- Technische Universität Berlin; Institut für Chemie; Straße des 17. Juni 124 10623 Berlin Deutschland
| |
Collapse
|
22
|
Two novel cyclic hexapeptides from the genetically engineered Actinosynnema pretiosum. Appl Microbiol Biotechnol 2016; 101:2273-2279. [DOI: 10.1007/s00253-016-8017-3] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2016] [Revised: 11/08/2016] [Accepted: 11/20/2016] [Indexed: 10/20/2022]
|
23
|
Affiliation(s)
- Silke C. Wenzel
- Saarland University; Department of Microbial Natural Products, Helmholtz-Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Pharmaceutical Biotechnology; Saarland University Campus, Building E8.1 66123 Saarbrücken Germany
| | - Rolf Müller
- Saarland University; Department of Microbial Natural Products, Helmholtz-Institute for Pharmaceutical Research Saarland, Helmholtz Centre for Infection Research and Pharmaceutical Biotechnology; Saarland University Campus, Building E8.1 66123 Saarbrücken Germany
| |
Collapse
|
24
|
Genome Analysis of the Fruiting Body-Forming Myxobacterium Chondromyces crocatus Reveals High Potential for Natural Product Biosynthesis. Appl Environ Microbiol 2016; 82:1945-1957. [PMID: 26773087 DOI: 10.1128/aem.03011-15] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2015] [Accepted: 01/10/2016] [Indexed: 11/20/2022] Open
Abstract
Here, we report the complete genome sequence of the type strain of the myxobacterial genus Chondromyces, Chondromyces crocatus Cm c5. It presents one of the largest prokaryotic genomes featuring a single circular chromosome and no plasmids. Analysis revealed an enlarged set of tRNA genes, along with reduced pressure on preferred codon usage compared to that of other bacterial genomes. The large coding capacity and the plethora of encoded secondary metabolite biosynthetic gene clusters are in line with the capability of Cm c5 to produce an arsenal of antibacterial, antifungal, and cytotoxic compounds. Known pathways of the ajudazol, chondramide, chondrochloren, crocacin, crocapeptin, and thuggacin compound families are complemented by many more natural compound biosynthetic gene clusters in the chromosome. Whole-genome comparison of the fruiting-body-forming type strain (Cm c5, DSM 14714) to an accustomed laboratory strain which has lost this ability (nonfruiting phenotype, Cm c5 fr-) revealed genetic changes in three loci. In addition to the low synteny found with the closest sequenced representative of the same family, Sorangium cellulosum, extensive genetic information duplication and broad application of eukaryotic-type signal transduction systems are hallmarks of this 11.3-Mbp prokaryotic genome.
Collapse
|
25
|
Khatri Y, Ringle. M, Lisurek M, von Kries JP, Zapp J, Bernhardt R. Substrate Hunting for the Myxobacterial CYP260A1 Revealed New 1α-Hydroxylated Products from C-19 Steroids. Chembiochem 2015; 17:90-101. [DOI: 10.1002/cbic.201500420] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/18/2015] [Indexed: 12/11/2022]
Affiliation(s)
- Yogan Khatri
- Universität des Saarlandes; Biochemie; Campus B2.2 66123 Saarbrücken Germany
| | - Michael Ringle.
- Universität des Saarlandes; Biochemie; Campus B2.2 66123 Saarbrücken Germany
| | - Michael Lisurek
- Forschungsinstitut für Molekulare Pharmakologie; Robert-Rössle-Strasse 10 13125 Berlin Germany
| | - Jens Peter von Kries
- Forschungsinstitut für Molekulare Pharmakologie; Robert-Rössle-Strasse 10 13125 Berlin Germany
| | - Josef Zapp
- Universität des Saarlandes; Pharmazeutische Biologie; Campus C2.2 66123 Saarbrücken Germany
| | - Rita Bernhardt
- Universität des Saarlandes; Biochemie; Campus B2.2 66123 Saarbrücken Germany
| |
Collapse
|
26
|
Abstract
Cyclic depsipeptides are polypeptides in which one or more amino acid is replaced by a hydroxy acid, resulting in the formation of at least one ester bond in the core ring structure. Many natural cyclic depsipeptides possessing intriguing structural and biological properties, including antitumor, antifungal, antiviral, antibacterial, anthelmintic, and anti-inflammatory activities, have been identified from fungi, plants, and marine organisms. In particular, the potent effects of cyclic depsipeptides on tumor cells have led to a number of clinical trials evaluating their potential as chemotherapeutic agents. Although many of the trials have not achieved the desired results, romidepsin (FK228), a bicyclic depsipeptide that inhibits histone deacetylase, has been shown to have clinical efficacy in patients with refractory cutaneous T-cell lymphoma and has received Food and Drug Administration approval for use in treatment. In this review, we discuss antitumor cyclic depsipeptides that have undergone clinical trials and focus on their structural features, mechanisms, potential applications in chemotherapy, and pharmacokinetic and toxicity data. The results of this study indicate that cyclic depsipeptides could be a rich source of new cancer therapeutics.
Collapse
|
27
|
Martinez JP, Sasse F, Brönstrup M, Diez J, Meyerhans A. Antiviral drug discovery: broad-spectrum drugs from nature. Nat Prod Rep 2015; 32:29-48. [PMID: 25315648 DOI: 10.1039/c4np00085d] [Citation(s) in RCA: 128] [Impact Index Per Article: 14.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Covering: up to April 2014. The development of drugs with broad-spectrum antiviral activities is a long pursued goal in drug discovery. It has been shown that blocking co-opted host-factors abrogates the replication of many viruses, yet the development of such host-targeting drugs has been met with scepticism mainly due to toxicity issues and poor translation to in vivo models. With the advent of new and more powerful screening assays and prediction tools, the idea of a drug that can efficiently treat a wide range of viral infections by blocking specific host functions has re-bloomed. Here we critically review the state-of-the-art in broad-spectrum antiviral drug discovery. We discuss putative targets and treatment strategies, with particular focus on natural products as promising starting points for antiviral lead development.
Collapse
Affiliation(s)
- J P Martinez
- Infection Biology Group, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
| | | | | | | | | |
Collapse
|
28
|
Biosynthesis of crocacin involves an unusual hydrolytic release domain showing similarity to condensation domains. ACTA ACUST UNITED AC 2014; 21:855-65. [PMID: 24981773 DOI: 10.1016/j.chembiol.2014.05.012] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2014] [Revised: 05/12/2014] [Accepted: 05/15/2014] [Indexed: 11/20/2022]
Abstract
The crocacins are potent antifungal and cytotoxic natural compounds from myxobacteria of the genus Chondromyces. Although total synthesis approaches have been reported, the molecular and biochemical basis guiding the formation of the linear crocacin scaffold has remained unknown. Along with the identification and functional analysis of the crocacin biosynthetic gene cluster from Chondromyces crocatus Cm c5, we here present the identification and biochemical characterization of an unusual chain termination domain homologous to condensation domains responsible for hydrolytic release of the product from the assembly line. In particular, gene inactivation studies and in vitro experiments using the heterologously produced domain CroK-C2 confirm this surprising role giving rise to the linear carboxylic acid. Additionally, we determined the kinetic parameters of CroK-C2 by monitoring hydrolytic cleavage of the substrate mimic N-acetylcysteaminyl-crocacin B using an innovative high-performance liquid chromatography mass spectrometry-based assay.
Collapse
|